Paper · 41449430
Role of TREM2 in neuroinflammation regulation: mechanisms, disease associations, and therapeutic translation advances.
Liao Y and 4 others. J Transl Med, 2025. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Role of TREM2 in neuroinflammation regulation: mechanisms, disease associations, and therapeutic translation advances. Papers, record 41449430. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449430
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of TREM2 in neuroinflammation regulation: mechanisms, disease associations, and therapeutic translation advances.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Immunologic | Major topic |
| Membrane Glycoproteins | Major topic |
| Neuroinflammatory Diseases | Major topic |
| Translational Research, Biomedical | Major topic |
| Inflammation | Major topic |
| Humans | |
| Animals | |
| Microglia | |
| Signal Transduction | |
| Ligands |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References206
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,672,320 | Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders. | Brain | 2021 | https://conductscience.org/library/papers/34672320 | PubMed |
| 2 | 37,917,301 | TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/37917301 | PubMed |
| 3 | 32,466,767 | TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice. | J Neuroinflammation | 2020 | https://conductscience.org/library/papers/32466767 | PubMed |
| 4 | 32,514,138 | Alzheimer's-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. | Nat Neurosci | 2020 | https://conductscience.org/library/papers/32514138 | PubMed |
| 5 | 33,065,553 | TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer's disease mice. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/33065553 | PubMed |
| 6 | 40,103,438 | TREM2 scFv-Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio-Immunotherapy. | Adv Mater | 2025 | https://conductscience.org/library/papers/40103438 | PubMed |
| 7 | 38,865,485 | Microglia promote maladaptive plasticity in autonomic circuitry after spinal cord injury in mice. | Sci Transl Med | 2024 | https://conductscience.org/library/papers/38865485 | PubMed |
| 8 | 39,758,888 | Perioperative enriched environment attenuates postoperative cognitive dysfunction by upregulating microglia TREM2 via PI3K/Akt pathway in mouse model of ischemic stroke. | Front Neurosci | 2024 | https://conductscience.org/library/papers/39758888 | PubMed |
| 9 | 35,382,840 | CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study. | J Neuroinflammation | 2022 | https://conductscience.org/library/papers/35382840 | PubMed |
| 10 | 26,949,937 | microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration. | PLoS One | 2016 | https://conductscience.org/library/papers/26949937 | PubMed |
1 to 10 of 206
See all 206 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,742,907 | Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42742907 | PubMed |
| 42,317,585 | Peripheral biomarkers of neuronal damage in neuropsychiatric systemic lupus erythematosus (NPSLE). | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/42317585 | PubMed |
| 41,888,656 | TREM2 contributes to central sensitization through PI3K/Akt/mTOR-mediated autophagic dysfunction in a rat model of vestibular migraine. | J Headache Pain | 2026 | https://conductscience.org/library/papers/41888656 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TREM2 | 54,209 | PubTator's text mining | https://conductscience.org/library/genes/54209 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41449430
GET https://conductscience.org/api/papers/v1/41449430/references?page=2